How well does Velsipity(Etrasimod) work?

Clinical trials demonstrated the drug's effectiveness in inducing and maintaining clinical remission.

Demonstrated Treatment Benefits

In clinical studies, a significantly greater proportion of patients treated with VELSIPITY achieved clinical remission and endoscopic improvement at both Week 12 and Week 52 compared to placebo. The treatment also demonstrated efficacy in achieving histologic-endoscopic mucosal improvement and corticosteroid-free clinical remission, supporting its role in managing ulcerative colitis.